![](https://www.mitacs.ca/wp-content/uploads/2023/12/generic-logo-background.png)
Extem supplies research grade mesenchymal stem cells (MSCs) and is looking to differentiate themselves by providing a proprietary human-derived growth media to replace the cow-derived fetal bovine serum (FBS) typically used. Pooled platelet lysate (PPL) may be a viable alternative. However, existing PPL methods lack quality control, standardization, and can result in up to 50% […]
Read More